文献速递胸部CT

个体化影像组学复合模型预测I期实性肺腺癌预后

An individualised radiomics composite model predicting prognosis of stage 1 solid lung adenocarcinoma.
PubMed 文献 · Clin Radiol · 2020-04-16

本研究回顾性纳入119例病理I期实性肺腺癌行肺叶切除术患者,从增强胸部CT提取397个影像组学特征,构建影像组学复合模型预测无病生存期并与简单影像组学模型比较。验证集中复合模型AUC为0.849(95%CI 0.783-0.898),高于简单影像组学模型的0.726(95%CI 0.681-0.770),复发率为22.6%。

要点

  • 影像组学复合模型在验证集预测DFS的AUC为0.849(95%CI 0.783-0.898)。
  • 简单影像组学模型验证集AUC为0.726(95%CI 0.681-0.770)。
  • 复合模型生存曲线可区分高风险与低风险患者。

核心结论

  • 个体化影像组学复合模型预测I期实性肺腺癌预后的准确性优于简单影像组学模型。

研究设计与样本

  • 回顾性纳入病理I期实性肺腺癌行肺叶切除术患者119例。
  • 从增强胸部CT提取每病灶397个影像组学特征。
  • 采用Spearman相关系数和LASSO回归降维筛选特征,单因素或多因素logistic回归构建预测模型。

诊断标准与关键数值

  • 验证集中病理TNM分期(第8版IASLC)AUC为0.587(95%CI 0.502-0.650)。
  • 验证集中临床病理模型AUC为0.629(95%CI 0.558-0.682)。
  • 验证集中影像组学模型AUC为0.726(95%CI 0.681-0.770)。
  • 验证集中影像组学复合模型AUC为0.849(95%CI 0.783-0.898)。
  • 复发率为22.6%。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To develop and evaluate a radiomics composite model for predicting disease-free survival (DFS) in stage I solid lung adenocarcinoma, and compare it to a simple radiomics model.

MATERIALS AND METHODS: Patients of pathological stage I solid lung adenocarcinoma treated with lobectomy (n = 119) were enrolled retrospectively. Three hundred and ninety-seven radiomics features per lesion were extracted from enhanced chest computed tomography (CT) imaging. Spearman's correlation coefficient and the LASSO (least absolute shrinkage and selection operator) regression model were used to reduce the dimension and select radiomics features. Univariate or multivariate logistic regression was used to build prediction models. A survival curve based on the radiomics composite model was plotted with Kaplan-Meier survival analysis to stratify the risk of recurrence. The confusion matrix, receiver operating characteristic (ROC) curve, and decision curve analysis were used to evaluate the performance of the prediction models.

RESULTS: Recurrence occurred in 22.6% of patients. The survival curve of the radiomics composite model could accurately differentiate high-risk from low-risk patients. In the validation sets, the areas under the ROC curves (AUCs) of the pathological TNM stage (8th IASLC), clinicopathological model, radiomics model, and radiomics composite model were 0.587 (95% confidence interval [CI] 0.502-0.650), 0.629 (95% CI 0.558-0.682), 0.726 (95% CI 0.681-0.770), and 0.849 (95% CI 0.783-0.898), respectively.

CONCLUSION: The prognosis of stage I solid lung adenocarcinoma predicted by an individualised radiomics composite model was more accurate than that of the simple radiomics model.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Chen H, Liang M, Li X, et al. An individualised radiomics composite model predicting prognosis of stage 1 solid lung adenocarcinoma. Clin Radiol. 2020. PMID: 32307110. doi:10.1016/j.crad.2020.03.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。